Yhn BusinessStartups first seen 1 d ago, last 21 min ago, peak #4
Open-source Covid-19 vaccine PVX-001 enters Phase 1 trial
Original: PVX-001: open-source Covid-19 vaccine starts Phase 1 trial
PopVax's PVX-001, an open-source Covid-19 vaccine, has begun its first Phase 1 clinical trial. The vaccine is being developed with a fully open approach, sharing its designs and research publicly, which is rare in the pharmaceutical industry. The news has drawn attention for the potential of open-source methods to make vaccine development cheaper and more accessible worldwide.
Why now: The combination of a clinical trial milestone and an unusual open-source approach to vaccine development is attracting attention.
Rank over time, top of the chart is #1. 65 snapshots from 1 d ago to 21 min ago.
Evidence
- PVX-001: open-source Covid-19 vaccine starts Phase 1 trial · jajoosam · 139
API: https://socialmediatrends-api.osmike.com/v1/trends/1751596